APPLIVER FIBROSIS
APPLIVER® is the new product obtained by the ABR innovative biotechnological platform NATRISE®.
Our research studies confirm the beneficial effect on health of APPLIVER® in metabolic disorder as NAFLD.
This makes APPLIVER® the perfect ingredient for dietary supplements and functional foods.
ABResearch srl
-
Country/Region:Italy
-
On CPHI since:2020
-
Certificates:3
-
Employees:25 - 49